Skip to content

These 5 Stocks Cost Little And Have “Mammoth Upside Potential”

“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” declares the author of today’s article of the five Buy-rated stocks trading under $10 that he highlights. Among them are a late-stage pharmaceutical company focused on developing potential new therapies for cancer, a security technology company that provides email encryption and data loss prevention services, and a small-cap oilfield services play. For these five stocks, CLICK HERE.